Novel insights into genetics and clinics of the HNF1A-MODY

Abdul-Rasoul M, Habib H, Al-Khouly M. ‘The honeymoon phase’ in children with type 1 diabetes mellitus: Frequency, duration, and influential factors. Pediatr Diabetes 7, 101–107, 2006.10.1111/j.1399-543X.2006.00155.xSearch in Google Scholar

Albert MA, Danielson E, Rifai N, Ridker PM. Effect of statin therapy on C-reactive protein levels: The pravastatin inflammation/CRP evaluation (PRINCE): A randomized trial and cohort study. J Am Med Assoc 286, 64–70, 2001.10.1001/jama.286.1.64Search in Google Scholar

Armendariz AD, Krauss RM. Hepatic nuclear factor 1-α: Inflammation, genetics, and atherosclerosis. Curr Opin Lipidol 20, 106–111, 2009.10.1097/MOL.0b013e3283295ee9Search in Google Scholar

Awa WL, Thon A, Raile K, Grulich-Henn J, Meissner T, Schober E, Holl RW. Genetic and clinical characteristics of patients with HNF1A gene variations from the German-Austrian DPV database. Eur J Endocrinol 164, 513–520, 2011.10.1530/EJE-10-0842Search in Google Scholar

Bach I, Galcheva-Gargova Z, Mattei MG, Simon-Chazottes D, Guenet JL, Cereghini S, Yaniv M. Cloning of human hepatic nuclear factor 1 (HNF1) and chromosomal localization of its gene in man and mouse. Genomics 8, 155–164, 1990.10.1016/0888-7543(90)90238-PSearch in Google Scholar

Bacon S, Engelbrecht B, Schmid J, Pfeiffer S, Gallagher R, McCarthy A, Burke M, Concannon C, Prehn JH, Byrne MM. MicroRNA-224 is readily detectable in urine of individuals with diabetes mellitus and is a potential indicator of beta-cell demise. Genes (Basel) 6, 399–416, 2015.10.3390/genes6020399448867126110317Search in Google Scholar

Bacon S, Kyithar MP, Schmid J, Pozza AC, Handberg A, Byrne MM. Circulating CD36 is reduced in HNF1A-MODY carriers. PloS one 8, e74577, 2013.10.1371/journal.pone.0074577377193324069322Search in Google Scholar

Ban N, Yamada Y, Someya Y, Miyawaki K, Ihara Y, Hosokawa M, Toyokuni S, Tsuda K, Seino Y. Hepatocyte nuclear factor-1alpha recruits the transcriptional co-activator p300 on the GLUT2 gene promoter. Diabetes 51, 1409–1418, 2002.10.2337/diabetes.51.5.140911978637Search in Google Scholar

Baumhueter S, Mendel DB, Conley PB, Kuo CJ, Turk C, Graves MK, Edwards CA, Courtois G, Crabtree GR. HNF-1 shares three sequence motifs with the POU domain proteins and is identical to LF-B1 and APF. Genes Dev 4, 372–379, 1990.10.1101/gad.4.3.3721970973Search in Google Scholar

Bazalova Z, Rypackova B, Broz J, Brunerova L, Polak J, Rusavy Z, Treslova L, Andel M. Three novel mutations in MODY and its phenotype in three different Czech families. Diabetes Res Clin Pract 88, 132–138, 2010.10.1016/j.diabres.2010.01.00520132997Search in Google Scholar

Bellanne-Chantelot C, Carette C, Riveline JP, Valero R, Gautier JF, Larger E, Reznik Y, Ducluzeau PH, Sola A, Hartemann-Heurtier A, Lecomte P, Chaillous L, Laloi-Michelin M, Wilhem JM, Cuny P, Duron F, Guerci B, Jeandidier N, Mosnier-Pudar H, Assayag M, Dubois-Laforgue D, Velho G, Timsit J. The type and the position of HNF1A mutation modulate age at diagnosis of diabetes in patients with maturity-onset diabetes of the young (MODY)-3. Diabetes 57, 503–508, 2008.10.2337/db07-085918003757Search in Google Scholar

Bellanne-Chantelot C, Coste J, Ciangura C, Fonfrede M, Saint-Martin C, Bouche C, Sonnet E, Valero R, Levy DJ, Dubois-Laforgue D, Timsit J. High-sensitivity C-reactive protein does not improve the differential diagnosis of HNF1A-MODY and familial young-onset type 2 diabetes: A grey zone analysis. Diabetes Metab 42, 33–37, 2016.10.1016/j.diabet.2015.02.00125753245Open DOISearch in Google Scholar

Berg LP, Scopes DA, Alhaq A, Kakkar VV, Cooper DN. Disruption of a binding site for hepatocyte nuclear factor 1 in the protein C gene promoter is associated with hereditary thrombophilia. Hum Mol Genet 3, 2147–2152, 1994.10.1093/hmg/3.12.21477881411Search in Google Scholar

Bjorkhaug L, Sagen JV, Thorsby P, Sovik O, Molven A, Njolstad PR. Hepatocyte nuclear factor-1α gene mutations and diabetes in Norway. J Clin Endocrinol Metab 88, 920–931, 2003.10.1210/jc.2002-02094512574234Search in Google Scholar

Bluteau O, Jeannot E, Bioulac-Sage P, Marques JM, Blanc JF, Bui H, Beaudoin JC, Franco D, Balabaud C, LaurentPuig P, Zucman-Rossi J. Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat Genet 32, 312–315, 2002.10.1038/ng100112355088Search in Google Scholar

Boj SF, Parrizas M, Maestro MA, Ferrer J. A transcription factor regulatory circuit in differentiated pancreatic cells. Proc Natl Acad Sci 98, 14481–14486, 2001.10.1073/pnas.2413493986470711717395Search in Google Scholar

Boj SF, Petrov D, Ferrer J. Epistasis of transcriptomes reveals synergism between transcriptional activators Hnf1α and Hnf4α. PLoS Genet 6, 5, 2010.10.1371/journal.pgen.1000970287774920523905Search in Google Scholar

Bonner C, Nyhan KC, Bacon S, Kyithar MP, Schmid J, Concannon CG, Bray IM, Stallings RL, Prehn JHM, Byrne MM. Identification of circulating microRNAs in HNF1A-MODY carriers. Diabetologia 56, 1743–1751, 2013.10.1007/s00125-013-2939-423674172Search in Google Scholar

Borowiec M, Antosik K, Fendler W, Deja G, Jarosz-Chobot P, Mysliwiec M, Zmyslowska A, Malecki M, Szadkowska A, Mlynarski W. Novel glucokinase mutations in patients with monogenic diabetes clinical outline of GCK-MD and potential for founder effect in Slavic population. Clin Genet 81, 278–283, 2012.10.1111/j.1399-0004.2011.01656.x2134886821348868Open DOISearch in Google Scholar

Borowiec M, Liew CW, Thompson R, Boonyasrisawat W, Hu J, Mlynarski WM, El Khattabi I, Kim SH, Marselli L, Rich SS, Krolewski AS, Bonner-Weir S, Sharma A, Sale M, Mychaleckyj JC, Kulkarni RN, Doria A. Mutations at the BLK locus linked to maturity onset diabetes of the young and beta-cell dysfunction. Proc Natl Acad Sci 106, 14460–14465, 2009.10.1073/pnas.0906474106273283319667185Search in Google Scholar

Brantjes H, Roose J, van De Wetering M, Clevers H. All Tcf HMG box transcription factors interact with Grouchorelated co-repressors. Nucleic Acids Res 29, 1410–1419, 2001.10.1093/nar/29.7.141011266540Open DOISearch in Google Scholar

Brial F, Lussier CR, Boudreau F. Loss of Hnf1a causes diabetes through enteroendocrine ghrelin upregulationin. Gastroenterology 144, S-34, 2013.10.1016/S0016-5085(13)60123-7Search in Google Scholar

Bulla G, Fournier RE. Genetic analysis of a transcriptional activation pathway by using hepatoma cell variants. Mol Cell Biol 14, 7086–7094, 1994.10.1128/MCB.14.11.7086Open DOISearch in Google Scholar

Byrne MM, Sturis J, Menzel S, Yamagata K, Fajans SS, Dronsfleld MJ, Bain SC, Hattersley AT, Velho G, Froguel P, Bell GI, Polonsky KS. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. Diabetes 45, 1503–1510, 1996.10.2337/diab.45.11.1503Open DOISearch in Google Scholar

Carbon S, Ireland A, Mungall CJ, Shu S, Marshall B, Lewis S, Hub A, Presence W, Group W. AmiGO: online access to ontology and annotation data. Bioinforma Appl NOTE 25, 288–289, 2009.10.1093/bioinformatics/btn615Search in Google Scholar

Chambers JC, Zhang W, Sehmi J, Li X, Wass MN, Van der Harst P, Holm H, Sanna S, Kavousi M, Baumeister SE, Coin LJ, Deng G, Gieger C, Heard-Costa NL, Hottenga JJ, Kuhnel B, Kumar V, Lagou V, Liang L, et al. Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet 43, 1131–1138, 2011.10.1038/ng.970Open DOISearch in Google Scholar

Chi YI, Frantz JD, Oh BC, Hansen L, Dhe-Paganon S, Shoelson SE. Diabetes mutations delineate an atypical POU domain in HNF-1α. Mol Cell 10, 1129–1137, 2002.10.1016/S1097-2765(02)00704-9Search in Google Scholar

Chi YI, Frantz JD, Oh BC, Hansen L, Dhe-Paganon S,Shoelson SE. Diabetes mutations delineate an atypical POU domain in HNF-1alpha. Mol Cell 10, 1129–1137, 2002.10.1016/S1097-2765(02)00704-9Search in Google Scholar

Chi YI. Homeodomain revisited: a lesson from disease-causing mutations. Hum Genet 116, 433–444, 2005.10.1007/s00439-004-1252-1157920415726414Search in Google Scholar

Chiu KC, Chuang LM, Ryu JM, Tsai GP, Saad MF. The I27L amino acid polymorphism of hepatic nuclear factor-1α is associated with insulin resistance. J Clin Endocrinol Metab 85, 2178–2183, 2000.10.1210/jc.85.6.2178Search in Google Scholar

Cleary M, Pendergrast PS, Herr W. Structural flexibility in transcription complex formation revealed by proteinDNA photocrosslinking. Proc Natl Acad Sci U S A 94, 8450–8455, 1997.10.1073/pnas.94.16.8450Open DOISearch in Google Scholar

Colclough K, Bellanne-Chantelot C, Saint-Martin C, Flanagan SE, Ellard S. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia. Hum Mutat 34, 669–685, 2013.10.1002/humu.22279Search in Google Scholar

Corrales PJP, Lopez Garrido MP, Rodriguez SA, Rubio LL, Lopez Jimenez LM, Oliveira CL, Alfaro Martinez JJ, Lozano Garcia JJ, Lopez AH, Castillo RR, Martinez JE, Romero FB. Clinical differences between patients with MODY-3, MODY-2 and type 2 diabetes mellitus with I27L polymorphism in the HNF1α gene. Endocrinol Nut 57, 4–8, 2010.10.1016/S1575-0922(10)70002-4Search in Google Scholar

Costa RH, Kalinichenko VV, Holterman AXL, Wang X. Transcription factors in liver development, differentiation, and regeneration. Hepatology 38, 1331–1347, 2003.10.1053/jhep.2003.09034Open DOISearch in Google Scholar

Courtois G, Baumhueter S, Crabtree GR. Purified hepatocyte nuclear factor 1 interacts with a family of hepatocytespecific promoters. Proc Natl Acad Sci U S A 85, 7937–7941, 1988.10.1073/pnas.85.21.79372823282460858Search in Google Scholar

D’Angelo A, Bluteau O, Garcia-Gonzalez MA, Gresh L, Doyen A, Garbay S, Robine S, Pontoglio M. Hepatocyte nuclear factor 1 and control terminal differentiation and cell fate commitment in the gut epithelium. Development 137, 1573–1582, 2010.10.1242/dev.04442020388655Search in Google Scholar

Dalgleish R, Flicek P, Cunningham F, Astashyn A, Tully RE, Proctor G, Chen Y, McLaren WM, Larsson P, Vaughan BW, Beroud C, Dobson G, Lehvaslaiho H, Taschner PE, den Dunnen JT, Devereau A, Birney E, Brookes AJ, Maglott DR. Locus Reference Genomic sequences: an improved basis for describing human DNA variants. Genome Med 2, 24, 2010.10.1186/gm145287380220398331Open DOISearch in Google Scholar

De Vas MG, Kopp JL, Heliot C, Sander M, Cereghini S, Haumaitre C. Hnf1b controls pancreas morphogenesis and the generation of Ngn3+ endocrine progenitors. Development 142, 871–882, 2015.10.1242/dev.110759435298125715395Search in Google Scholar

Divine JK, Staloch LJ, Haveri H, Jacobsen CM, Wilson DB, Heikinheimo M, Simon TC. GATA-4, GATA-5, and GATA-6 activate the rat liver fatty acid binding protein gene in concert with HNF-1alpha. Am J Physiol Gastrointest Liver Physiol 287, G1086–G1099, 2004.10.1152/ajpgi.00421.200314715527Search in Google Scholar

Dohda T, Kaneoka H, Inayoshi Y, Kamihira M, Miyake K, Iijima S. Transcriptional coactivators CBP and p300 cooperatively enhance HNF-1alpha-mediated expression of the albumin gene in hepatocytes. J Biochem 136, 313–319, 2004.10.1093/jb/mvh12315598887Search in Google Scholar

Dukes ID, Sreenan S, Roe MW, Levisetti M, Zhou YP, Ostrega D, Bell GI, Pontoglio M, Yaniv M, Philipson L, Polonsky KS. Defective pancreatic beta-cell glycolytic signaling in hepatocyte nuclear factor-1alpha-deficient mice. J Biol Chem 273, 24457–24464, 1998.10.1074/jbc.273.38.24457Search in Google Scholar

Dusatkova P, Pruhova S, Sumnik Z, Kolouskova S, Obermannova B, Lebl J. HNF1A mutation presenting with fetal macrosomia and hypoglycemia in childhood prior to onset of overt diabetes. J Pediatr Endocr Met 24, 377–379, 2011.10.1515/jpem.2011.083Search in Google Scholar

Eastman Q, Grosschedl R. Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Curr Opin Cell Biol 11, 233–240, 1999.10.1016/S0955-0674(99)80031-3Open DOISearch in Google Scholar

Edlund H. Transcribing pancreas. Diabetes 47, 1817–1823, 1998.10.2337/diabetes.47.12.18179836511Open DOISearch in Google Scholar

Eeckhoute J, Formstecher P, Laine B. Hepatocyte nuclear factor 4α enhances the hepatocyte nuclear factor 1α-mediated activation of transcription. Nucleic Acids Res 32, 2586–2593, 2004.10.1093/nar/gkh58141946915141028Search in Google Scholar

Eide S, Rder H, Johansson S, Midthjell K, Svik O, Njlstad PR, Molven A. Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study). Diabet Med 25, 775–781, 2008.10.1111/j.1464-5491.2008.02459.x18513305Search in Google Scholar

Ellard S, Bellanne-Chantelot C, Hattersley AT. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 51, 546–553, 2008.10.1007/s00125-008-0942-y18297260227036018297260Open DOISearch in Google Scholar

Ellard S, Colclough K. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young. Hum Mutat 27, 854–869, 2006.10.1002/humu.2035716917892Open DOISearch in Google Scholar

Estrada K, Aukrust I, Bjorkhaug L, Burtt NP, Mercader JM, Garcia-Ortiz H, Huerta-Chagoya A, Moreno-Macias H, Walford G, Flannick J, Williams AL, Gomez-Vazquez MJ, Fernandez-Lopez JC, Martinez-Hernandez A, Centeno-Cruz F, Mendoza-Caamal E, Revilla-Monsalve C, Islas-Andrade S, Cordova EJ, et al. Association of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population. JAMA 311, 2305, 2014.10.1001/jama.2014.6511442585024915262Search in Google Scholar

Ewing RM, Chu P, Elisma F, Li H, Taylor P, Climie S, McBroom-Cerajewski L, Robinson MD, O’Connor L, Li M, Taylor R, Dharsee M, Ho Y, Heilbut A, Moore L, Zhang S, Ornatsky O, Bukhman YV, Ethier M, Sheng Y, Vasilescu J, Abu-Farha M, Lambert JP, Duewel HS, Stewart, II, Kuehl B, Hogue K, Colwill K, Gladwish K, Muskat B, Kinach R, Adams SL, Moran MF, Morin GB, Topaloglou T, Figeys D. Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol 3, 89, 2007.10.1038/msb4100134184794817353931Open DOISearch in Google Scholar

Fagerberg L, Hallstrom BM, Oksvold P, Kampf C, Djureinovic D, Odeberg J, Habuka M, Tahmasebpoor S, Danielsson A, Edlund K, Asplund A, Sjostedt E, Lundberg E, Szigyarto CAK, Skogs M, Takanen JO, Berling H, Tegel H, Mulder J, et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics 13, 397–406, 2014.10.1074/mcp.M113.03560024309898Open DOISearch in Google Scholar

Fahey ME, Bennett MJ, Mahon C, Jager S, Pache L, Kumar D, Shapiro A, Rao K, Chanda SK, Craik CS, Frankel AD, Krogan NJ. GPS-Prot: A web-based visualization platform for integrating host-pathogen interaction data. BMC Bioinformatics 12, 298, 2011.2177747510.1186/1471-2105-12-298Search in Google Scholar

Fajans S, Bell G, Polonsky K. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 345, 971–980, 2001.10.1056/NEJMra002168Search in Google Scholar

Fernandez-Zapico ME, van Velkinburgh JC, Gutierrez-Aguilar R, Neve B, Froguel P, Urrutia R, Stein R. MODY7 gene, KLF11, is a novel p300-dependent regulator of Pdx-1 (MODY4) transcription in pancreatic islet beta cells. J Biol Chem 284, 36482–36490, 2009.10.1074/jbc.M109.028852Search in Google Scholar

Ferrer J. A genetic switch in pancreatic β-cells: implications for differentiation and haploinsufficiency. Diabetes 51, 2355–2362, 2002.10.2337/diabetes.51.8.235512145145Open DOISearch in Google Scholar

Fokkema IFAC, Taschner PEM, Schaafsma GCP, Celli J, Laros JFJ, den Dunnen JT. LOVD v.2.0: the next generation in gene variant databases. Hum Mutat 32, 557–563, 2011.10.1002/humu.21438Search in Google Scholar

Froguel P, Velho G. Molecular genetics of maturity-onset diabetes of the young. Trends Endocrinol Metab 10, 142–146, 1999.10.1016/S1043-2760(98)00134-9Search in Google Scholar

Funk WD, Wright WE. Cyclic amplification and selection of targets for multicomponent complexes: myogenin interacts with factors recognizing binding sites for basic helix-loop-helix, nuclear factor 1, myocyte-specific enhancer-binding factor 2, and COMP1 factor. Proc Natl Acad Sci U S A 89, 9484–9488, 1992.10.1073/pnas.89.20.9484501561329097Search in Google Scholar

Galan M, Garcia-Herrero CM, Azriel S, Gargallo M, Duran M, Gorgojo JJ, Andia VM, Navas MA. Differential effects of HNF-1α mutations associated with familial young-onset diabetes on target gene regulation. Mol Med 17, 256–265, 2011.10.2119/molmed.2010.00097306097421170474Open DOISearch in Google Scholar

Gaulton KJ, Ferreira T, Lee Y, Raimondo A, Magi R, Reschen ME, Mahajan A, Locke A, William Rayner N, Robertson N, Scott RA, Prokopenko I, Scott LJ, Green T, Sparso T, Thuillier D, Yengo L, Grallert H, Wahl S, et al. Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat Genet 47, 1415–1425, 2015.Search in Google Scholar

Geer LY, Marchler-Bauer A, Geer RC, Han L, He J, He S, Liu C, Shi W, Bryant SH. The NCBI BioSystems database. Nucleic Acids Res 38, 492–496, 2009.10.1093/nar/gkp858280889619854944Search in Google Scholar

Godart F, Bellanne-Chantelot C, Clauin S, Gragnoli C, Abderrahmani A, Blanche H, Boutin P, Chevre JC, Froguel P, Bailleul B. Identification of seven novel nucleotide variants in the hepatocyte nuclear factor-1α (TCF1) promoter region in MODY patients. Hum Mutat 15, 173–180, 2000.10.1002/(SICI)1098-1004(200002)15:2<173::AID-HUMU6>3.0.CO;2-WOpen DOISearch in Google Scholar

Gragnoli C, Lindner T, Cockburn BN, Kaisaki PJ, Gragnoli F, Marozzi G, Bell GI. Maturity-onset diabetes of the young due to a mutation in the hepatocyte nuclear factor-4 alpha binding site in the promoter of the hepatocyte nuclear factor-1 alpha gene. Diabetes 46, 1648–1651, 1997.10.2337/diabetes.46.10.1648Search in Google Scholar

Grimm AA, Brace CS, Wang T, Stormo GD, Imai S. A nutrient-sensitive interaction between Sirt1 and HNF-1alpha regulates Crp expression. Aging Cell 10, 305–317, 2011.10.1111/j.1474-9726.2010.00667.xSearch in Google Scholar

Harries LW, Brown JE, Gloyn AL. Species-specific differences in the expression of the HNF1A, HNF1B and HNF4A genes. PLoS One 4, 2009.10.1371/journal.pone.0007855Search in Google Scholar

Harries LW, Ellard S, Stride A, Morgan NG, Hattersley AT, Vaxillaire M, Tuomi T, Barbetti E, Njolstad PR, Hansen T, Costa A, Congret I, Pedersen O, Sovik O, Lorini R, Froguel P. Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes. Hum Mol Genet 15, 2216–2224, 2006.10.1093/hmg/ddl147Open DOISearch in Google Scholar

Hegele RA, Cao H, Harris SB, Hanley AJG, Zinman B. The hepatic nuclear factor-1α G319S variant is associated with early-onset Type 2 diabetes in Canadian Oji-Cree. J Clin Endocrinol Metab 84, 1077–1082, 1999.10.1210/jc.84.3.1077Search in Google Scholar

Hiraiwa H, Pan CJ, Lin B, Akiyama TE, Gonzalez FJ, Chou JY. A molecular link between the common phenotypes of Type 1 glycogen storage disease and HNF1α-null mice. J Biol Chem 276, 7963–7967, 2001.10.1074/jbc.M010523200Search in Google Scholar

Holmkvist J, Cervin C, Lyssenko V, Winckler W, Anevski D, Cilio C, Almgren P, Berglund G, Nilsson P, Tuomi T, Lindgren CM, Altshuler D, Groop L. Common variants in HNF-1 α and risk of type 2 diabetes. Diabetologia 49, 2882–2891, 2006.10.1007/s00125-006-0450-xSearch in Google Scholar

Hoskins JW, Jia J, Flandez M, Parikh H, Xiao W, Collins I, Emmanuel MA, Ibrahim A, Powell J, Zhang L, Malats N, Bamlet WR, Petersen GM, Real FX, Amundadottir LT. Transcriptome analysis of pancreatic cancer reveals a tumor suppressor function for HNF1A. Carcinogenesis 35, 2670–2678, 2014.10.1093/carcin/bgu193Search in Google Scholar

Hua Q, Zhao M, Narayana N, Nakagawa SH, Jia W, Weiss MA. Diabetes-associated mutations in a beta -cell transcription factor destabilize an antiparallel ‘mini-zipper’ in a dimerization interface. Proc Natl Acad Sci 97, 1999–2004, 2000.10.1073/pnas.97.5.1999Search in Google Scholar

Ishigaki K, Namba H, Nakashima M, Nakayama T, Mitsutake N, Hayashi T, Maeda S, Ichinose M, Kanematsu T, Yamashita S. Aberrant localization of beta-catenin correlates with overexpression of its target gene in human papillary thyroid cancer. J Clin Endocrinol Metab 87, 3433–3440, 2002.10.1210/jcem.87.7.8648Search in Google Scholar

Ishii Y, Hansen AJ, Mackenzie PI. Octamer transcription factor-1 enhances hepatic nuclear factor-1alpha-mediated activation of the human UDP glucuronosyltransferase 2B7 promoter. Mol Pharmacol 57, 940–947, 2000.Search in Google Scholar

Jacquemin P, Lemaigre FP, Rousseau GG. The Onecut transcription factor HNF-6 (OC-1) is required for timely specification of the pancreas and acts upstream of Pdx-1 in the specification cascade. Dev Biol 258, 105–116, 2003.10.1016/S0012-1606(03)00115-5Search in Google Scholar

Jeannot E, Mellottee L, Bioulac-Sage P, Balabaud C, Scoazec JY, Van Nhieu JT, Bacq Y, Michalak S, Buob D, LaurentPuig P, Rusyn I, Zucman-Rossi J. Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage. Diabetes 59, 1836–1844, 2010.10.2337/db09-1819288978620393147Search in Google Scholar

Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K, Schadt EE, Kaplan L, Bennett D, Li Y, Tanaka T, Voight BF, Bonnycastle LL, Jackson AU, Crawford G, Surti A, Guiducci C, Burtt NP, Parish S, Clarke R, et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 41, 56–65, 2009.10.1038/ng.291288167619060906Search in Google Scholar

Kherra S, Blouin JL, Santoni F, Schwitzgebel V. Precision medicine for monogenic diabetes: from a survey to the development of a next-generation diagnostic panel. Swiss Med Wkly 147, w14535, 2017.10.4414/smw.2017.1453529120028Search in Google Scholar

Klupa T, Warram JH, Antonellis A, Pezzolesi M, Nam M, Malecki MT, Doria A, Rich SS, Krolewski AS. Determinants of the development of diabetes (maturity-onset diabetes of the young-3) in carriers of HNF-1alpha mutations: evidence for parent-of-origin effect. Diabetes Care 25, 2292–2301, 2002.10.2337/diacare.25.12.229212453976Open DOISearch in Google Scholar

Koepsell H, Lips K, Volk C. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 24, 1227–1251, 2007.10.1007/s11095-007-9254-z1747395917473959Open DOISearch in Google Scholar

Kohler S, Vasilevsky NA, Engelstad M, Foster E, McMurry J, Ayme S, Baynam G, Bello SM, Boerkoel CF, Boycott KM, Brudno M, Buske OJ, Chinnery PF, Cipriani V, Connell LE, Dawkins HJS, DeMare LE, Devereau AD, de Vries BBA, et al. The human phenotype ontology in 2017.Nucleic Acids Res 45, D865–D876, 2017.10.1093/nar/gkw1039521053527899602Open DOISearch in Google Scholar

Kotlyar M, Pastrello C, Sheahan N, Jurisica I. Integrated interactions database: tissue-specific view of the human and model organism interactomes. Nucleic Acids Res 44, D536–D541, 2016.10.1093/nar/gkv1115470281126516188Open DOISearch in Google Scholar

Kritis AA, Ktistaki E, Barda D, Zannis VI, Talianidis L. An indirect negative autoregulatory mechanism involved in hepatocyte nuclear factor-1 gene expression. Nucleic Acids Res 21, 5882–5889, 1993.10.1093/nar/21.25.58823104698290348Open DOISearch in Google Scholar

Kuo CJ, Conley PB, Chen L, Sladek FM, Darnell JE, Crabtree GR. A transcriptional hierarchy involved in mammalian cell-type specification. Nature 355, 457–461, 1992.10.1038/355457a01734282Search in Google Scholar

Lau HH, Ng NHJ, Loo LSW, Jasmen JB, Teo AKK. The molecular functions of hepatocyte nuclear factors – In and beyond the liver. J Hepatol 68, 1033–1048, 2018.10.1016/j.jhep.2017.11.0262917524329175243Open DOISearch in Google Scholar

Lausen J, Thomas H, Lemm I, Bulman M, Borgschulze M, Lingott A, Hattersley AT, Ryffel GU. Naturally occurring mutations in the human HNF4alpha gene impair the function of the transcription factor to a varying degree. Nucleic Acids Res 28, 430–437, 2000.10.1093/nar/28.2.4301060664010251710606640Open DOISearch in Google Scholar

Lebenthal Y, Fisch Shvalb N, Gozlan Y, Tenenbaum A, Tenenbaum-Rakover Y, Vaillant E, Froguel P, Vaxillaire M, Gat-Yablonski G. The unique clinical spectrum of maturity onset diabetes of the young type 3. Diabetes Res Clin Pract 135, 18–22, 2018.10.1016/j.diabres.2017.10.02429107759Search in Google Scholar

Lee YH, Sauer B, Gonzalez FJ. Laron dwarfism and non-insulin-dependent diabetes mellitus in the Hnf-1alpha knockout mouse. Mol Cell Biol 18, 3059–3068, 1998.10.1128/MCB.18.5.30591106849566924Open DOISearch in Google Scholar

Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O’Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB, Tukiainen T, Birnbaum DP, Kosmicki JA, Duncan LE, Estrada K, Zhao F, Zou J, Pierce-Hoffman E, Berghout J, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285–291, 2016.10.1038/nature19057501820727535533Search in Google Scholar

Leu JI, Crissey MA, Leu JP, Ciliberto G, Taub R. Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury. Mol Cell Biol 21, 414–424, 2001.10.1128/MCB.21.2.414-424.20018658511134330Search in Google Scholar

Ley SH, Hegele RA, Connelly PW, Harris SB, Mamakeesick M, Cao H, Gittelsohn J, Retnakaran R, Zinman B, Hanley AJ. Assessing the association of the HNF1A G319S variant with C-reactive protein in Aboriginal Canadians: A population-based epidemiological study. Cardiovasc Diabetol 9, 1–6, 2010.10.1186/1475-2840-9-39292921920716378Open DOISearch in Google Scholar

Li J, Ning G, Duncan SA. Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. Genes Dev 14, 464–474, 2000.10.1101/gad.14.4.464Search in Google Scholar

Lim S, Jin K, Friedman E. Mirk protein kinase is activated by MKK3 and functions as a transcriptional activator of HNF1alpha. J Biol Chem 277, 25040–25046, 2002.10.1074/jbc.M20325720011980910Search in Google Scholar

Luni C, Marth JD, Doyle FJ. Computational Modeling of Glucose Transport in Pancreatic β-Cells Identifies Metabolic Thresholds and Therapeutic Targets in Diabetes. PLoS One 7, e53130, 2012.10.1371/journal.pone.0053130353136623300881Search in Google Scholar

Luo Z, Li Y, Wang H, Fleming J, Li M, Kang Y, Zhang R, Li D. Hepatocyte nuclear factor 1A (HNF1A) as a possible tumor suppressor in pancreatic cancer. PLoS One 10, e0121082, 2015.10.1371/journal.pone.0121082436863525793983Search in Google Scholar

Lussier CR, Brial F, Roy SAB, Langlois MJ, Verdu EF, Rivard N, Perreault N, Boudreau F. Loss of hepatocyte-nuclearfactor-1α impacts on adult mouse intestinal epithelial cell growth and cell lineages differentiation. PLoS One 5, e12378, 2010.10.1371/journal.pone.0012378292753820808783Search in Google Scholar

MacArthur J, Bowler E, Cerezo M, Gil L, Hall P, Hastings E, Junkins H, McMahon A, Milano A, Morales J, Pendlington ZM, Welter D, Burdett T, Hindorff L, Flicek P, Cunningham F, Parkinson H. The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog). Nucleic Acids Res 45, D896–D901, 2017.10.1093/nar/gkw1133521059027899670Open DOISearch in Google Scholar

Magee TR, Cai Y, El-Houseini ME, Locker J, Wan YJ. Retinoic acid mediates down-regulation of the alpha-fetoprotein gene through decreased expression of hepatocyte nuclear factors. J Biol Chem 273, 30024–30032, 1998.10.1074/jbc.273.45.300249792724Search in Google Scholar

Majidi S, Fouts A, Pyle L, Chambers C, Armstrong T, Wang Z, Batish SD, Klingensmith G, Steck AK. Can biomarkers help target maturity-onset diabetes of the young genetic testing in antibody-negative diabetes? Diabetes Technol Ther 20, 106–112, 2018.2935543610.1089/dia.2017.0317611012029355436Search in Google Scholar

McDonald TJ, Colclough K, Brown R, Shields B, Shepherd M, Bingley P, Williams A, Hattersley AT, Ellard S. Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from Type1 diabetes. Diabet Med 28, 1028–1033, 2011a.10.1111/j.1464-5491.2011.03287.x21395678Search in Google Scholar

McDonald TJ, Ellard S. Maturity onset diabetes of the young: Identification and diagnosis. Ann Clin Biochem 50, 403–415, 2013.10.1177/00045632134834582387834923878349Open DOISearch in Google Scholar

McDonald TJ, McEneny J, Pearson ER, Thanabalasingham G, Szopa M, Shields BM, Ellard S, Owen KR, Malecki MT, Hattersley AT, Young IS. Lipoprotein composition in HNF1A-MODY: Differentiating between HNF1AMODY and Type 2 diabetes. Clin Chim Acta 413, 927–932, 2012.10.1016/j.cca.2012.02.00522360925Search in Google Scholar

McDonald TJ, Shields BM, Lawry J, Owen KR, Gloyn AL, Ellard S, Hattersley AT. High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes. Diabetes Care 34, 1860–1862, 2011b.10.2337/dc11-0323314201721700917Search in Google Scholar

Mendel D, Crabtree G. Hnf-1, a member of a novel class of dimerizing homeodomain proteins. J Biol Chem 266, 677–680, 1991.10.1016/S0021-9258(17)35222-5Search in Google Scholar

Mendel DB, Hansen LP, Graves MK, Conley PB, Crabtree GR. HNF-1 alpha and HNF-1 beta (vHNF-1) share dimerization and homeo domains, but not activation domains, and form heterodimers in vitro. Genes Dev 5, 1042–1056, 1991.10.1101/gad.5.6.10422044952Search in Google Scholar

Mendel DB, Khavari PA, Conley PB, Graves MK, Hansen LP, Admon A, Crabtree GR. Characterization of a cofactor that regulates dimerization of a mammalian homeodomain protein. Science 254, 1762–1767, 1991.10.1126/science.17633251763325Search in Google Scholar

Miles RR, Crockett DK, Lim MS, Elenitoba-Johnson KS. Analysis of BCL6-interacting proteins by tandem mass spectrometry. Mol Cell Proteomics 4, 1898–1909, 2005.10.1074/mcp.M500112-MCP20016147992Open DOISearch in Google Scholar

Mitchelmore C, Troelsen JT, Spodsberg N, Sjostrom H, Noren O. Interaction between the homeodomain proteins Cdx2 and HNF1alpha mediates expression of the lactase-phlorizin hydrolase gene. Biochem J 346 Pt 2, 529–535, 2000.10.1042/bj3460529Search in Google Scholar

Miyamoto-Sato E, Fujimori S, Ishizaka M, Hirai N, Masuoka K, Saito R, Ozawa Y, Hino K, Washio T, Tomita M, Yamashita T, Oshikubo T, Akasaka H, Sugiyama J, Matsumoto Y, Yanagawa H. A comprehensive resource of interacting protein regions for refining human transcription factor networks. PLoS One 5, e9289, 2010.10.1371/journal.pone.0009289282753820195357Search in Google Scholar

Mrozinska S, Radkowski P, Gosiewski T, Szopa M, Bulanda M, Ludwig-Galezowska AH, Morawska I, Sroka-Oleksiak A, Matejko B, Kapusta P, Salamon D, Malecki MT, Wolkow P, Klupa T. Qualitative parameters of the colonic flora in patients with HNF1A-MODY are different from those observed in Type 2 diabetes mellitus. J Diabetes Res 2016, 1–9, 2016.10.1155/2016/3876764507866327807544Search in Google Scholar

Mughal SA, Park R, Nowak N, Gloyn AL, Karpe F, Matile H, Malecki MT, Mccarthy MI, Stoffel M, Owen KR. Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes. Diabet Med 30, 246–250, 2013.10.1111/dme.12066419353623157689Search in Google Scholar

Najmi LA, Aukrust I, Flannick J, Molnes J, Burtt N, Molven A, Groop L, Altshuler D, Johansson S, Bjorkhaug L, Njolstad PR. Functional investigations of HNF1A identify rare variants as risk factors for Type 2 diabetes in the general population. Diabetes 66, 335–346, 2017.10.2337/db16-046027899486586026327899486Open DOISearch in Google Scholar

Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 409, 194–198, 2001.10.1038/3505158711196643Search in Google Scholar

Nammo T, Yamagata K, Tanaka T, Kodama T, Sladek FM, Fukui K, Katsube F, Sato Y, Miyagawa J, Shimomura I. Expression of HNF-4α (MODY1), HNF-1β (MODY5), and HNF-1α (MODY3) proteins in the developing mouse pancreas. Gene Expr Patterns 8, 96–106, 2008.10.1016/j.modgep.2007.09.00617996499Search in Google Scholar

Naqvi AAT, Hasan GM, Hassan MI. Investigating the role of transcription factors of pancreas development in pancreatic cancer. Pancreatology 18, 184–190, 2018.10.1016/j.pan.2017.12.01329289465Open DOISearch in Google Scholar

Narayana N, Hua QX, Weiss MA. The dimerization domain of HNF-1α: Structure and plasticity of an intertwined four-helix bundle with application to diabetes mellitus. J Mol Biol 310, 635–658, 2001.10.1006/jmbi.2001.478011439029Search in Google Scholar

Nowak N, Hohendorff J, Solecka I, Szopa M, Skupien J, Kiec-Wilk B, Mlynarski W, Malecki MT. Circulating ghrelin level is higher in HNF1A–MODY and GCK–MODY than in polygenic forms of diabetes mellitus. Endocrine 50, 643–649, 2015.10.1007/s12020-015-0627-5466270925987348Search in Google Scholar

Nowak N, Szopa M, Thanabalasingham G, McDonald TJ, Colclough K, Skupien J, James TJ, Kiec-Wilk B, Kozek E, Mlynarski W, Hattersley AT, Owen KR, Malecki MT. Cystatin C is not a good candidate biomarker for HNF1A-MODY. Acta Diabetol 50, 815–820, 2013.10.1007/s00592-012-0378-1389813122350134Search in Google Scholar

Nyunt O, Wu JY, McGown IN, Harris M, Huynh T, Leong GM, Cowley DM, Cotterill AM. Investigating maturity onset diabetes of the young. Clin Biochem Rev 30, 67–74, 2009.Search in Google Scholar

O’Brien VP, Bokelmann K, Ramirez J, Jobst K, Ratain MJ, Brockmoller J, Tzvetkov M. Hepatocyte nuclear factor 1 regulates the expression of the organic cation transporter 1 via binding to an evolutionary conserved region in intron 1 of the OCT1 gene. J Pharmacol Exp Ther 347, 181–192, 2013.10.1124/jpet.113.206359378141323922447Search in Google Scholar

O’Leary NA, Wright MW, Brister JR, Ciufo S, Haddad D, McVeigh R, Rajput B, Robbertse B, Smith-White B, AkoAdjei D, Astashyn A, Badretdin A, Bao Y, Blinkova O, Brover V, Chetvernin V, Choi J, Cox E, Ermolaeva O, et al. Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res 44, D733–D745, 2016.10.1093/nar/gkv1189470284926553804Open DOISearch in Google Scholar

Odom DT, Zizlsperger H, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, Volkert TL, Schreiber J, Rolfe PA, Gifford DK, Fraenkel E, Bell GI, Young RA. Control of pancreas and liver gene expression by HNF transcription factors. Science 303, 1378–1381, 2004.10.1126/science.1089769301262414988562Search in Google Scholar

Oram RA, Jones AG, Besser REJ, Knight BA, Shields BM, Brown RJ, Hattersley AT, McDonald TJ. The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells. Diabetologia 57, 187–191, 2014.10.1007/s00125-013-3067-x385552924121625Search in Google Scholar

Owen K, Thanabalasingham G, Juszczak A. Biomarkers for MODY subtypes [internet]. Diapedia 4104526113 rev. no. 29, 2014. Available from: https://doi.org/10.14496/dia.4104526113.2910.14496/dia.4104526113.29Search in Google Scholar

Owen KR, Thanabalasingham G, James TJ, Karpe F, Farmer AJ, McCarthy MI, Gloyn AL. Assessment of highsensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations. Diabetes Care 33, 1919–1924, 2010.10.2337/dc10-0288Search in Google Scholar

Parrizas M, Maestro MA, Boj SF, Paniagua A, Casamitjana R, Gomis R, Rivera F, Ferrer J. Hepatic nuclear factor 1-alpha directs nucleosomal hyperacetylation to its tissue-specific transcriptional targets. Mol Cell Biol 21, 3234–3243, 2001.10.1128/MCB.21.9.3234-3243.2001Open DOISearch in Google Scholar

Pavic T, Juszczak A, Pape Medvidovic E, Burrows C, Sekerija M, Bennett AJ, Cuca Knezevic J, Gloyn AL, Lauc G, McCarthy MI, Gornik O, Owen KR. Maturity onset diabetes of the young due to HNF1A variants in Croatia. Biochemia medica 28, 1–11, 2018.10.11613/BM.2018.020703Open DOISearch in Google Scholar

Pearson ER, Liddell WG, Shepherd M, Corrall RJ, Hattersley AT. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes. Diabet Med 17, 543–545, 2000.10.1046/j.1464-5491.2000.00305.xSearch in Google Scholar

Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 362, 1275–1281, 2003.10.1016/S0140-6736(03)14571-0Search in Google Scholar

Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 111, 1805–1812, 2003.10.1172/JCI200318921Search in Google Scholar

Pierce BL, Ahsan H. Genome-wide ‘pleiotropy scan’ identifies HNF1A region as a novel pancreatic cancer susceptibility locus. Cancer Res 71, 4352–4358, 2011.10.1158/0008-5472.CAN-11-0124Search in Google Scholar

Plengvidhya N, Kooptiwut S, Songtawee N, Doi A, Furuta H, Nishi M, Nanjo K, Tantibhedhyangkul W, Boonyasrisawat W, Yenchitsomanus PT, Doria A, Banchuin N. PAX4 mutations in Thais with maturity onset diabetes of the young. J Clin Endocrinol Metab 92, 2821–2826, 2007.10.1210/jc.2006-192717426099Open DOISearch in Google Scholar

Pontoglio M, Barra J, Hadchouel M, Doyen A, Kress C, Bach JP, Babinet C, Yaniv M. Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell 84, 575–585, 1996.10.1016/S0092-8674(00)81033-8Search in Google Scholar

Pontoglio M, Prie D, Cheret C, Doyen A, Leroy C, Froguel P, Velho G, Yaniv M, Friedlander G. HNF1α controls renal glucose reabsorption in mouse and man. EMBO Rep 1, 359–365, 2000.10.1093/embo-reports/kvd071108374511269503Search in Google Scholar

Pontoglio M, Sreenan S, Roe M, Pugh W, Ostrega D, Doyen A, Pick AJ, Baldwin A, Velho G, Froguel P, Levisetti M, Bonner-Weir S, Bell GI, Yaniv M, Polonsky KS. Defective insulin secretion in hepatocyte nuclear factor 1α-deficient mice. J Clin Invest 101, 2215–2222, 1998.10.1172/JCI25485088099593777Search in Google Scholar

Prudente S, Jungtrakoon P, Marucci A, Ludovico O, Buranasupkajorn P, Mazza T, Hastings T, Milano T, Morini E, Mercuri L, Bailetti D, Mendonca C, Alberico F, Basile G, Romani M, Miccinilli E, Pizzuti A, Carella M, Barbetti F, et al. Loss-of-function mutations in APPL1 in familial diabetes mellitus. Am J Hum Genet 97, 177–185, 2015.10.1016/j.ajhg.2015.05.011457100226073777Search in Google Scholar

Pruhova S, Dusatkova P, Neumann D, Hollay E, Cinek O, Lebl J, Sumnik Z. Two cases of diabetic ketoacidosis in HNF1A-MODY linked to severe dehydration: is it time to change the diagnostic criteria for MODY? Diabetes Care 36, 2573–2574, 2013.10.2337/dc13-0058374793023610083Search in Google Scholar

Pruhova S, Dusatkova P, Sumnik Z, Kolouskova S, Pedersen O, Hansen T, Cinek O, Lebl J. Glucokinase diabetes in 103 families from a country-based study in the Czech Republic: geographically restricted distribution of two prevalent GCK mutations. Pediatr Diabetes 11, 529–535, 2010.10.1111/j.1399-5448.2010.00646.x20337973Open DOISearch in Google Scholar

Qin J, Zhai J, Hong R, Shan S, Kong Y, Wen Y, Wang Y, Liu J, Xie Y. Prospero-related homeobox protein (Prox1) inhibits hepatitis B virus replication through repressing multiple cis regulatory elements. J Gen Virol 90, 1246–1255, 2009.10.1099/vir.0.006007-019264593Search in Google Scholar

Rebouissou S, Vasiliu V, Thomas C, Bellanne-Chantelot C, Bui H, Chretien Y, Timsit J, Rosty C, Laurent-Puig P, Chauveau D, Zucman-Rossi J. Germline hepatocyte nuclear factor 1α and 1β mutations in renal cell carcinomas. Hum Mol Genet 14, 603–614, 2005.10.1093/hmg/ddi05715649945Open DOISearch in Google Scholar

Reiner AP, Barber MJ, Guan Y, Ridker PM, Lange LA, Chasman DI, Walston JD, Cooper GM, Jenny NS, Rieder MJ, Durda JP, Smith JD, Novembre J, Tracy RP, Rotter JI, Stephens M, Nickerson DA, Krauss RM. Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1α are associated with C-reactive protein. Am J Hum Genet 82, 1193–1201, 2008.10.1016/j.ajhg.2008.03.017242731818439552Search in Google Scholar

Ress A, Moelling K. Bcr interferes with beta-catenin-Tcf1 interaction. FEBS Lett 580, 1227–1230, 2006.10.1016/j.febslet.2006.01.03416442529Search in Google Scholar

Rho H, Jones CN, Rose RB. Kinetic stability may determine the interaction dynamics of the bifunctional protein DCoH1, the dimerization cofactor of the transcription factor HNF-1alpha. Biochemistry 49, 10187–10197, 2010.10.1021/bi101505621047120Search in Google Scholar

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17, 405–424, 2015.10.1038/gim.2015.30454475325741868Open DOISearch in Google Scholar

Rose RB, Bayle JH, Endrizzi JA, Cronk JD, Crabtree GR, Alber T. Structural basis of dimerization, coactivator recognition and MODY3 mutations in HNF-1α. Nat Struct Biol 7, 744–748, 2000a.10.1038/7896610966642Search in Google Scholar

Rose RB, Endrizzi JA, Cronk JD, Holton J, Alber T. High-resolution structure of the HNF-1α dimerization domain. Biochemistry 39, 15062–15070, 2000b.10.1021/bi001996t11106484Search in Google Scholar

Ryffel GU. Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: Functional and pathological consequences. J Mol Endocrinol 27, 11–29, 2001.10.1677/jme.0.027001111463573Search in Google Scholar

Sabatti C, Service SK, Hartikainen AL, Pouta A, Ripatti S, Brodsky J, Jones CG, Zaitlen NA, Varilo T, Kaakinen M, Sovio U, Ruokonen A, Laitinen J, Jakkula E, Coin L, Hoggart C, Collins A, Turunen H, Gabriel S, et al. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet 41, 35–46, 2009.10.1038/ng.271268707719060910Open DOISearch in Google Scholar

Scherer SE, Muzny DM, Buhay CJ, Chen R, Cree A, Ding Y, Dugan-Rocha S, Gill R, Gunaratne P, Harris RA, Hawes AC, Hernandez J, Hodgson AV, Hume J, Jackson A, Khan ZM, Kovar-Smith C, Lewis LR, Lozado RJ, et al. The finished DNA sequence of human chromosome 12. Nature 440, 346–351, 2006.10.1038/nature0456916541075Search in Google Scholar

Schober E, Rami B, Grabert M, Thon A, Kapellen T, Reinehr T, Holl RW. Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with Type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database. Diabet Med 26, 466–473, 2009.10.1111/j.1464-5491.2009.02720.x19646184Search in Google Scholar

Schwitzgebel VM. Many faces of monogenic diabetes. J Diabetes Investig 5, 121–133, 2014.10.1111/jdi.12197402357224843749Search in Google Scholar

Shah N, Thanabalasingham G, Owen KR, James TJ. Comparability of high-sensitivity CRP methods to detect maturity-onset diabetes of the young due to HNF1A mutations. Br J Biomed Sci 71, 84–85, 2014.10.1080/09674845.2014.1197828824974685Search in Google Scholar

Shepherd M, Pearson ER, Houghton J, Salt G, Ellard S, Hattersley AT. No deterioration in glycemic control in HNF1alpha maturity-onset diabetes of the young following transfer from long-term insulin to sulphonylureas. Diabetes Care 26, 3191–3192, 2003.10.2337/diacare.26.11.3191-a14578267Open DOISearch in Google Scholar

Shepherd M, Shields B, Ellard S, Rubio-Cabezas O, Hattersley AT. A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients. Diabet Med 26, 437–441, 2009.10.1111/j.1464-5491.2009.02690.x19388975Search in Google Scholar

Shi TT, Yang FY, Liu C, Cao X, Lu J, Zhang XL, Yuan MX, Chen C, Yang JK. Angiotensin-converting enzyme 2 regulates mitochondrial function in pancreatic β-cells. Biochem Biophys Res Commun 495, 860–866, 2018.10.1016/j.bbrc.2017.11.05529128354Search in Google Scholar

Shields BM, Colclough K. Towards a systematic nationwide screening strategy for MODY. Diabetologia 60, 609–612, 2017.10.1007/s00125-017-4213-72813210028132100Open DOISearch in Google Scholar

Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT, Ellard S. Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 53, 2504–2508, 2010.10.1007/s00125-010-1799-420499044Search in Google Scholar

Shields BM, McDonald TJ, Ellard S, Campbell MJ, Hyde C, Hattersley AT. The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes. Diabetologia 55, 1265–1272, 2012.2221869810.1007/s00125-011-2418-8332867622218698Search in Google Scholar

Shih D, Bussen M, Sehayek E. Hepatocyte nuclear factor-1 is an essential regulator of bile acid and plasma cholesterol metabolism. Nature 27, 379–382, 2001a.10.1038/8687111279518Search in Google Scholar

Shih D, Screenan S, Munoz K, Diabetes LP. Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes 50, 2472–2480, 2001b.10.2337/diabetes.50.11.247211679424Search in Google Scholar

Shih DQ, Stoffel M. Dissecting the transcriptional network of pancreatic islets during development and differentiation. Proc Natl Acad Sci 98, 14189–14191, 2001.10.1073/pnas.2515589986465511734636Open DOISearch in Google Scholar

Shu Y, Sheardown SA, Brown C, Owen RP, Zhang S, Castro RA, Ianculescu AG, Yue L, Lo JC, Burchard EG, Brett CM, Giacomini KM. Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J Clin Invest 117, 1422–1431, 2007.10.1172/JCI30558185725917476361Search in Google Scholar

Simaite D, Kofent J, Gong M, Ruschendorf F, Jia S, Arn P, Bentler K, Ellaway C, Kuhnen P, Hoffmann GF, Blau N, Spagnoli FM, Hubner N, Raile K. Recessive mutations in PCBD1 cause a new type of early-onset diabetes. Diabetes 63, 3557–3564, 2014.10.2337/db13-178424848070Search in Google Scholar

Skupien J, Gorczynska-Kosiorz S, Klupa T, Cyganek K, Wanic K, Borowiec M, Sieradzki J, Malecki MT. Molecular background and clinical characteristics of HNF1A MODY in a Polish population. Diabetes Metab 34, 524–528, 2008.10.1016/j.diabet.2008.05.00418838325Search in Google Scholar

Sneha P, Thirumal KD, George PDC, Siva R, Zayed H. Determining the role of missense mutations in the POU domain of HNF1A that reduce the DNA-binding affinity: A computational approach. PLoS One 12, 2017.10.1371/journal.pone.0174953539192628410371Search in Google Scholar

Soeki T, Sata M. Inflammatory biomarkers and atherosclerosis. Int Heart J 57, 134–139, 2016.10.1536/ihj.15-34626973275Open DOISearch in Google Scholar

Sourdive DJ, Transy C, Garbay S, Yaniv M. The bifunctional DCOH protein binds to HNF1 independently of its 4-alpha-carbinolamine dehydratase activity. Nucleic Acids Res 25, 1476–1484, 1997.10.1093/nar/25.8.14761466279092652Open DOISearch in Google Scholar

Soutoglou E, Papafotiou G, Katrakili N, Talianidis I. Transcriptional activation by hepatocyte nuclear factor-1 requires synergism between multiple coactivator proteins. J Biol Chem 275, 12515–12520, 2000.10.1074/jbc.275.17.1251510777539Search in Google Scholar

Stanescu D, Hughes N, Kaplan B, Stanley C, De Leon D. Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A. J Clin Endocrinol Metab 97, 2026–2030, 2012.10.1210/jc.2012-1356367429622802087Search in Google Scholar

Stanik J, Dusatkova P, Cinek O, Valentinova L, Huckova M, Skopkova M, Dusatkova L, Stanikova D, Pura M, Klimes I, Lebl J, Gasperikova D, Pruhova S. De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumed. Diabetologia 57, 480–484, 2014.10.1007/s00125-013-3119-224323243Search in Google Scholar

Steele AM, Shields BM, Shepherd M, Ellard S, Hattersley AT, Pearson ER. Increased all-cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the HNF1A gene. Diabet Med 27, 157–161, 2010.10.1111/j.1464-5491.2009.02913.x20546258Search in Google Scholar

Stenson PD, Mort M, Ball EV, Shaw K, Phillips AD, Cooper DN. The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet 133, 1–9, 2014.10.1007/s00439-013-1358-4389814124077912Search in Google Scholar

Stoffers DA, Ferrer J, Clarke WL, Habener JF. Early-onset type-ll diabetes mellitus (MODY4) linked to IPF1. Nat Genet 17, 138–139, 1997.10.1038/ng1097-1389326926Search in Google Scholar

Stride A, Vaxillaire M, Tuomi T, Barbetti F, Njolstad PR, Hansen T, Costa A, Conget I, Pedersen O, Sovik O, Lorini R, Groop L, Froguel P, Hattersley AT. The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia 45, 427–435, 2002.10.1007/s00125-001-0770-911914749Open DOISearch in Google Scholar

Sur I, Taipale J. Genetic evidence that HNF-1alpha-dependent transcriptional control of HNF-4alpha is essential for human pancreatic beta cell function. Nat Rev Cancer 110, 827–833, 2016.10.1172/JCI0215085Search in Google Scholar

Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, Jensen LJ, von Mering C. The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible. Nucleic Acids Res 45, D362–D368, 2017.10.1093/nar/gkw937521063727924014Open DOISearch in Google Scholar

Szopa M, Klupa T, Kapusta M, Matejko B, Ucieklak D, Glodzik W, Zapala B, Sani CM, Hohendorff J, Malecki MT, Skupien J. A decision algorithm to identify patients with high probability of monogenic diabetes due to HNF1A mutations. Endocrine 64, 1–7, 2019.10.1007/s12020-019-01863-7645387330778899Search in Google Scholar

Szpirer J, Pedeutour F, Kesti T, Riviere M, Syvaoja JE, Turc-Carel C, Szpirer C. Localization of the gene for DNA polymerase epsilon (POLE) to human chromosome 12q24.3 and rat chromosome 12 by somatic cell hybrid panels and fluorescence in situ hybridization. Genomics 20, 223–226, 1994.10.1006/geno.1994.11568020968Search in Google Scholar

Taneera J, Storm P, Groop L. Downregulation of type II diabetes mellitus and maturity onset diabetes of young pathways in human pancreatic islets from hyperglycemic donors. J Diabetes Res 2014, 237535, 2014.10.1155/2014/237535421262825379510Search in Google Scholar

Thanabalasingham G, Owen KR. Diagnosis and management of maturity onset diabetes of the young (MODY). BMJ 343, 6044, 2011.10.1136/bmj.d604422012810Search in Google Scholar

Thanabalasingham G, Shah N, Vaxillaire M, Hansen T, Tuomi T, Gasperikova D, Szopa M, Tjora E, James TJ, Kokko P, Loiseleur F, Andersson E, Gaget S, Isomaa B, Nowak N, Raeder H, Stanik J, Njolstad PR, Malecki MT, et al. A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes. Diabetologia 54, 2801–2810, 2011.10.1007/s00125-011-2261-y21814873Search in Google Scholar

Tzvetkov MV, Saadatmand AR, Bokelmann K, Meineke I, Kaiser R, Brockmoller J. Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT3 antagonists tropisetron and ondansetron. Pharmacogenomics J 12, 22–29, 2012.10.1038/tpj.2010.7520921968Search in Google Scholar

Tzvetkov MV, Saadatmand AR, Lotsch J, Tegeder I, Stingl JC, Brockmoller J. Genetically polymorphic OCT1: another piece in the puzzle of the variable pharmacokinetics and pharmacodynamics of the opioidergic drug Tramadol. Clin Pharmacol Ther 90, 143–150, 2011.10.1038/clpt.2011.5621562485Search in Google Scholar

Urbanova J, Rypackova B, Prochazkova Z, Kucera P, Cerna M, Andel M, Heneberg P. Positivity for islet cell autoantibodies in patients with monogenic diabetes is associated with later diabetes onset and higher HbA _1c level. Diabet Med 31, 466–471, 2014.10.1111/dme.1231424102923Search in Google Scholar

van Wering HM, Huibregtse IL, van der Zwan SM, de Bie MS, Dowling LN, Boudreau F, Rings EH, Grand RJ, Krasinski SD. Physical interaction between GATA-5 and hepatocyte nuclear factor-1alpha results in synergistic activation of the human lactase-phlorizin hydrolase promoter. J Biol Chem 277, 27659–27667, 2002.10.1074/jbc.M203645200Search in Google Scholar

Vaxillaire M, Abderrahmani A, Boutin P, Bailleul B, Froguel P, Yaniv M, Pontoglio M. Anatomy of a homeoprotein revealed by the analysis of human MODY3 mutations. J Biol Chem 274, 35639–35646, 1999.10.1074/jbc.274.50.35639Search in Google Scholar

Vaxillaire M, Froguel P. Monogenic diabetes: Implementation of translational genomic research towards precision medicine. J Diabetes 8, 782–795, 2016.10.1111/1753-0407.12446Search in Google Scholar

Vesterhus M, Haldorsen I, Ræder H, Molven A, Njolstad P. Reduced pancreatic volume in hepatocyte nuclear factor 1A-maturity-onset diabetes of the young. J Clin Endocrinol Metab 93, 3505–3509, 2008.10.1210/jc.2008-0340Search in Google Scholar

Wang H, Maechler P, Antinozzi PA, Hagenfeldt KA, Wollheim CB. Hepatocyte nuclear factor 4α regulates the expression of pancreatic β-cell genes implicated in glucose metabolism and nutrient-induced insulin secretion. J Biol Chem 275, 35953–35959, 2000.10.1074/jbc.M006612200Search in Google Scholar

Wang J, Huo K, Ma L, Tang L, Li D, Huang X, Yuan Y, Li C, Wang W, Guan W, Chen H, Jin C, Wei J, Zhang W, Yang Y, Liu Q, Zhou Y, Zhang C, Wu Z, Xu W, Zhang Y, Liu T, Yu D, Zhang Y, Chen L, Zhu D, Zhong X, Kang L, Gan X, Yu X, Ma Q, Yan J, Zhou L, Liu Z, Zhu Y, Zhou T, He F, Yang X. Toward an understanding of the protein interaction network of the human liver. Mol Syst Biol 7, 536, 2011.10.1038/msb.2011.6721988832Open DOISearch in Google Scholar

Wu KJ, Wilson DR, Shih C, Darlington GJ. The transcription factor HNF1 acts with C/EBP alpha to synergistically activate the human albumin promoter through a novel domain. J Biol Chem 269, 1177–1182, 1994.10.1016/S0021-9258(17)42239-3Search in Google Scholar

Wu B, Piloto S, Zeng W, Hoverter NP, Schilling TF, Waterman ML. Ring Finger Protein 14 is a new regulator of TCF/β-catenin-mediated transcription and colon cancer cell survival. EMBO Rep 14, 347–355, 2013.2344949910.1038/embor.2013.19361565423449499Search in Google Scholar

Wu Y, Liu H, Shi X, Yao Y, Yang W, Song Y. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma. Oncotarget 6, 9160–9172, 2015.10.18632/oncotarget.3247449620925863539Search in Google Scholar

Yang Q, Yamagata K, Yamamoto K, Miyagawa J, Takeda J, Iwasaki N, Iwahashi H, Yoshiuchi I, Namba M, Miyazaki J, Hanafusa T, Matsuzawa Y. Structure/function studies of hepatocyte nuclear factor-1α, a diabetes-associated transcription factor. Biochem Biophys Res Commun 266, 196–202, 1999.10.1006/bbrc.1999.174710581189Search in Google Scholar

Yang X, Song JH, Cheng Y, Wu W, Bhagat T, Yu Y, Abraham JM, Ibrahim S, Ravich W, Roland BC, Khashab M, Singh VK, Shin EJ, Yang X, Verma AK, Meltzer SJ, Mori Y. Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells. Gut 63, 881–890, 2014.10.1136/gutjnl-2013-305266461263924000294Search in Google Scholar

Yu M, Wang J, Li W, Yuan YZ, Li CY, Qian XH, Xu WX, Zhan YQ, Yang XM. Proteomic screen defines the hepatocyte nuclear factor 1alpha-binding partners and identifies HMGB1 as a new cofactor of HNF1alpha. Nucleic Acids Res 36, 1209–1219, 2008.10.1093/nar/gkm1131227509918160415Search in Google Scholar

Zhu H, Leung SW. Identification of microRNA biomarkers in type 2 diabetes: a meta-analysis of controlled profiling studies. Diabetologia 58, 900–911, 2015.10.1007/s00125-015-3510-225677225Search in Google Scholar

Zou Y, Lim S, Lee K, Deng X, Friedman E. Serine/threonine kinase Mirk/Dyrk1B is an inhibitor of epithelial cell migration and is negatively regulated by the Met adaptor Ran-binding protein M. J Biol Chem 278, 49573–49581, 2003.10.1074/jbc.M30755620014500717Search in Google Scholar